Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Zinman

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|October 21, 2015
A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemiaS Heller, C Mathieu, R Kapur, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2015
Glycaemic efficacy of canagliflozin is largely independent of baseline β-cell function or insulin sensitivityD R Matthews, B Zinman, C Tong, et al.
Diabetes|April 1, 1996
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humansG F Lewis, B Zinman, Y Groenewoud, et al.
Diabetes|May 1, 1988
Counterregulatory hormone responses preserved after long-term intravenous insulin infusion compared to continuous subcutaneous insulin infusionM Gulan, K Perlman, M Sole, et al.
Clinical Biochemistry|June 26, 1999
Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitusR A Hegele, S B Harris, A J Hanley, et al.
Diabetes Care|July 2, 1999
Cultural adaptation of the diabetes quality-of-life measure for Chinese patientsA Y Cheng, E Y Tsui, A J Hanley, et al.
IEEE Transactions on Bio-Medical Engineering|October 1, 1981
Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cellH M Broekhuyse, J D Nelson, B Zinman, et al.
Lancet (London, England)|June 28, 1980
Role of continuous component in subcutaneous "open-loop" insulin deliveryJ D Nelson, E B Marliss, A M Albisser, et al.
Diabetes, Obesity & Metabolism|September 3, 2011
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programmeB Zinman, W E Schmidt, A Moses, et al.
Diabetes Care|July 1, 1987
Controlled crossover study of subcutaneous and intravenous insulin infusion in type I diabetesM Gulan, K Perlman, A M Albisser, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Diabetic Medicine : a Journal of the British Diabetic Association|October 21, 2015
A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemiaS Heller, C Mathieu, R Kapur, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2015
Glycaemic efficacy of canagliflozin is largely independent of baseline β-cell function or insulin sensitivityD R Matthews, B Zinman, C Tong, et al.
Diabetes|April 1, 1996
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humansG F Lewis, B Zinman, Y Groenewoud, et al.
Diabetes|May 1, 1988
Counterregulatory hormone responses preserved after long-term intravenous insulin infusion compared to continuous subcutaneous insulin infusionM Gulan, K Perlman, M Sole, et al.
Clinical Biochemistry|June 26, 1999
Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitusR A Hegele, S B Harris, A J Hanley, et al.
Diabetes Care|July 2, 1999
Cultural adaptation of the diabetes quality-of-life measure for Chinese patientsA Y Cheng, E Y Tsui, A J Hanley, et al.
IEEE Transactions on Bio-Medical Engineering|October 1, 1981
Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cellH M Broekhuyse, J D Nelson, B Zinman, et al.
Lancet (London, England)|June 28, 1980
Role of continuous component in subcutaneous "open-loop" insulin deliveryJ D Nelson, E B Marliss, A M Albisser, et al.
Diabetes, Obesity & Metabolism|September 3, 2011
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programmeB Zinman, W E Schmidt, A Moses, et al.
Diabetes Care|July 1, 1987
Controlled crossover study of subcutaneous and intravenous insulin infusion in type I diabetesM Gulan, K Perlman, A M Albisser, et al.
Pageof 22